Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Loratadine Under Fasting Conditions · 1 trial · 1 indication
| Arm | Type | Description |
|---|---|---|
| 1 | EXPERIMENTAL | Loratadine 10 mg Tablets Under Fasting Conditions (Sandoz, Inc.) |
| 2 | EXPERIMENTAL | Loratadine 10 mg Tablets Under Fed Conditions (Sandoz, Inc.) |
| 3 | ACTIVE_COMPARATOR | Claritin (Loratadine) 10 mg Tablets Under Fed Conditions (Schering) |
| Name | Type | Description |
|---|---|---|
| Loratadine 10 mg Tablets Under Fasting Conditions (Sandoz, Inc.) | DRUG | - |
| Loratadine 10 mg Tablets Under Fed Conditions (Sandoz, Inc.) | DRUG | - |
| Claritin (Loratadine) 10 mg Tablets Under Fed Conditions (Schering) | DRUG | - |
Inclusion Criteria: * No clinically significant abnormal finding on physical exam, medical history, or clinical laboratory results on screening. Exclusion Criteria: * Positive test results for HIV or hepatitis B or C. * Treatment for drug or alcohol dependence.